Clinical trial
Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative Colitis
NCT01790061 is registered in ClinicalTrials.gov with The Second Hospital of Nanjing Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy, Durability and Safety of Standardized Fecal Microbiota Transplantation in Patients With Moderate to Severe Ulcerative Colitis
- Lead sponsor
- The Second Hospital of Nanjing Medical University
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- February 28, 2013
- Completion date
- December 31, 2025
- Enrollment
- 500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bacteria, fecal microbiota transplantation, inflammatory bowel disease, microbiota, ulcerative colitis